Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
4 (not assignable)

Data source

Referenceopen allclose all

Reference Type:
other: study report
Title:
Skin sensitisation data for 57-10-3
Author:
Cosmetic Ingredient Review
Year:
2005
Bibliographic source:
Cosmetic Ingredient Review; Final Report of the Cosmetic Ingredient Review Expert Panel; Final Report on the Safety Assessment of Oleic Acid, Lauric Acid, Palmitic Acid, Myristic Acid, and Stearic Acid; p. 53, June 2005.
Reference Type:
other: Authoritative data base
Title:
HSDB number : 5001
Author:
HSDB Database
Year:
2011
Bibliographic source:
HSDB (Cosmetic Ingredient Review; Final Report of the Cosmetic Ingredient Review Expert Panel; Final Report on the Safety Assessment of Oleic Acid, Lauric Acid, Palmitic Acid, Myristic Acid, and Stearic Acid; p. 53, June 2005.)

Materials and methods

Principles of method if other than guideline:
Standard Schwartz-Peck procedure.
GLP compliance:
not specified
Type of study:
patch test
Justification for non-LLNA method:
not specified

Test material

Constituent 1
Reference substance name:
Palmatic acid
IUPAC Name:
Palmatic acid
Constituent 2
Reference substance name:
Palmitic acid
EC Number:
200-312-9
EC Name:
Palmitic acid
Cas Number:
57-10-3
IUPAC Name:
palmitic acid
Test material form:
solid: crystalline
Details on test material:
- Name of test material (as cited in study report):Palmitic acid
- Molecular formula (if other than submission substance):C16H32O2
- Substance type:Organic

In vivo test system

Test animals

Species:
human
Sex:
male/female

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
other: closed and open patches
Vehicle:
no data
Concentration / amount:
A shave cream formulation containing 2.2% Palmitic Acid
Challengeopen allclose all
Route:
other: skin
Vehicle:
no data
Concentration / amount:
A shave cream formulation containing 2.2% Palmitic Acid
No. of animals per dose:
101 human
Details on study design:
INDUCTION EXPOSURE
- No. of exposures:Two
- Exposure period:24-hr
- Site:Closed and open
- Duration:10-14 days
- Concentrations:2.2%
Positive control substance(s):
not specified

Results and discussion

In vivo (non-LLNA)

Results
Reading:
1st reading
Group:
test chemical
Dose level:
2.2%
No. with + reactions:
3
Total no. in group:
101
Clinical observations:
There were 3 reactions of mild to intense erythema to the closed challenge patch and the formulation was considered " nonsensitizing ".
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. Group: test group. Dose level: 2.2%. No with. + reactions: 3.0. Total no. in groups: 101.0. Clinical observations: There were 3 reactions of mild to intense erythema to the closed challenge patch and the formulation was considered " nonsensitizing "..

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
In a prophetic patch test, a shave cream formulation containing 2.2% Palmitic Acid was tested for sensitization of the skin of 101 human subjects. Two 24-hr closed and open patches are usually applied to the skin 10-14 days apart in the standard Schwartz-Peck procedure. There were 3 reactions of mild to intense erythema to the closed challenge patch and the formulation was considered " nonsensitizing."
Executive summary:

In a prophetic patch test, a shave cream formulation containing 2.2% Palmitic Acid was tested for sensitization of the skin of 101 human subjects. Two 24-hr closed and open patches are usually applied to the skin 10-14 days apart in the standard Schwartz-Peck procedure. There were 3 reactions of mild to intense erythema to the closed challenge patch and the formulation was considered " nonsensitizing."